UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052302
Receipt number R000058717
Scientific Title A beore-after study on the effectiveness of the self-care application "HerLife" for menopausal symptoms
Date of disclosure of the study information 2023/09/25
Last modified on 2024/06/21 18:27:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A before-after comparison study of a novel self-care application to develop an individualized lifestyle intervention to prevent and manage menopausal symptoms

Acronym

Menopausal symptoms self-care application before-after study

Scientific Title

A beore-after study on the effectiveness of the self-care application "HerLife" for menopausal symptoms

Scientific Title:Acronym

HerLife berfore-after study

Region

Japan


Condition

Condition

Menopausal symptoms

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effectiveness of the self-care application 'HerLife', which includes a patient-reported outcome recording function and rule-based self-care suggestions for menopausal women.
To cross-sectionally examine the association between physical characteristics and lifestyle, including nutrient deficiencies, particularly iron deficiency, and menopausal symptoms.
To develop effective personalized lifestyle interventions based on analysis using AI algorithms based on machine learning and deep learning.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Severity of menopausal symptoms: Modified version of the menopausal symptoms rating chart for Japanese women (26 weeks after the start of the intervention)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

The subjects will download the "Her Life" smartphone app (YStory Inc. / Japan) on their own iPhone and use it for 6 months (26 weeks).
They will enter their symptoms into the app daily, and the researchers will look at the subject's symptom tracking data and measurement data for the past month and pick up the next month's health care plan from existing algorithms.
The each subject will work on improving her lifestyle based on the health care plans and enter the actual actions she has taken into the app, reading columns about health information in the app.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

45 years-old <=

Age-upper limit

55 years-old >=

Gender

Female

Key inclusion criteria

Japanese women with irregular or absent menstrual cycles and menopausal symptoms
Employed (full-time, temporary, or part-time, 3 or more days per week)
The simplified menopausal index (SMI) score is between 25 and 66 points.
Own an iPhone (iOS 16 or later) and can use mobile communication daily.
Able to communicate and use apps in Japanese without any problems.

Key exclusion criteria

Those with the following comorbidities: coronary artery disease, pheochromocytoma, neurasthenia, psychiatric disorders, uncontrolled thyroid dysfunction, uncontrolled hypertension or any other comorbidity that the doctor considers unsuitable for study participation
Those who have started using new drugs (e.g. hormone replacement therapy or antidepressants) within 30 days
Those who are pregnant or lactating

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Miho
Middle name
Last name Egawa

Organization

Kyoto University Graduate School of Medicine

Division name

Department of Gynecology and Obstetrics

Zip code

606-8507

Address

54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto

TEL

075-751-3269

Email

megawa@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Ohsuga
Middle name
Last name Takuma

Organization

Kyoto University Graduate School of Medicine

Division name

Department of Gynecology and Obstetrics

Zip code

606-8507

Address

54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto

TEL

075-751-3269

Homepage URL


Email

ohsuga@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

YStory Inc.

Name of secondary funder(s)

Ministry of Economy, Trade and Industry


IRB Contact (For public release)

Organization

Kyoto University Graduate School and Faculty of Medicine, Ethics Committee

Address

Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, JAPAN

Tel

075-753-4680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 09 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 09 Month 21 Day

Date of IRB

2023 Year 09 Month 21 Day

Anticipated trial start date

2023 Year 09 Month 22 Day

Last follow-up date

2024 Year 10 Month 16 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 09 Month 25 Day

Last modified on

2024 Year 06 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058717